Clinical Trial Update: Selinexor in Patients With Advanced Thymoma and Thymic Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for selinexor in patients with advanced thymoma and thymic epithelial tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thymic Epithelial Tumor
• Thymoma

Drugs mentioned

• Selinexor (selinexor)

Snippet

Sponsor: Morten Mau-Soerensen | Conditions: Thymoma, Advanced Thymic Epithelial Tumour | Phase 2 | Status: UNKNOWN